Evidence map›Paper›PMID 33436544›Full record

ArticleTranslational psychiatry2021

A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data.

Jakub Tomasik, Sung Yeon Sarah Han, Giles Barton-Owen, Dan-Mircea Mirea, Nayra A Martin-Key, Nitin Rustogi, Santiago G Lago, Tony Olmert, Jason D Cooper, Sureyya Ozcan and 10 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 3 countries.

Jakub TomasikDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK. jt455@cam.ac.uk.ORCID 0000-0002-2127-4487
Sung Yeon Sarah HanDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Giles Barton-OwenPsyomics Ltd, Cambridge, UK.
Dan-Mircea MireaDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Nayra A Martin-KeyDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Nitin RustogiDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Santiago G LagoDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3276-430X
Tony OlmertDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4641-6442
Jason D CooperDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Sureyya OzcanDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID 0000-0002-9371-3696
Pawel EljaszDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Grégoire ThomasSQU4RE, Roeselare, Belgium.ORCID 0000-0002-6247-9438
Robin TuyttenMetabolomic Diagnostics, Little Island, Cork, Ireland.ORCID 0000-0002-8734-7335
Tim MetcalfePsyomics Ltd, Cambridge, UK.
Thea S ScheiPsyomics Ltd, Cambridge, UK.ORCID 0000-0002-0063-9707
Lynn P FarragPsyomics Ltd, Cambridge, UK.
Lauren V FriendPsyomics Ltd, Cambridge, UK.
Emily BellPsyomics Ltd, Cambridge, UK.
Dan CowellPsyomics Ltd, Cambridge, UK.
Sabine BahnDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK. sb209@cam.ac.uk.
University of Cambridge · GBKPMG (United Kingdom) · GBMiddle East Technical University · TRPrinceton University · US

Funding

Stanley Medical Research Institute (SMRI) 07R-1888
6 · The paper itself

Abstract

The vast personal and economic burden of mood disorders is largely caused by their under- and misdiagnosis, which is associated with ineffective treatment and worsening of outcomes. Here, we aimed to develop a diagnostic algorithm, based on an online questionnaire and blood biomarker data, to reduce the misdiagnosis of bipolar disorder (BD) as major depressive disorder (MDD). Individuals with depressive symptoms (Patient Health Questionnaire-9 score ≥5) aged 18-45 years were recruited online. After completing a purpose-built online mental health questionnaire, eligible participants provided dried blood spot samples for biomarker analysis and underwent the World Health Organization World Mental Health Composite International Diagnostic Interview via telephone, to establish their mental health diagnosis. Extreme Gradient Boosting and nested cross-validation were used to train and validate diagnostic models differentiating BD from MDD in participants who self-reported a current MDD diagnosis. Mean test area under the receiver operating characteristic curve (AUROC) for separating participants with BD diagnosed as MDD (N = 126) from those with correct MDD diagnosis (N = 187) was 0.92 (95% CI: 0.86-0.97). Core predictors included elevated mood, grandiosity, talkativeness, recklessness and risky behaviour. Additional validation in participants with no previous mood disorder diagnosis showed AUROCs of 0.89 (0.86-0.91) and 0.90 (0.87-0.91) for separating newly diagnosed BD (N = 98) from MDD (N = 112) and subclinical low mood (N = 120), respectively. Validation in participants with a previous diagnosis of BD (N = 45) demonstrated sensitivity of 0.86 (0.57-0.96). The diagnostic algorithm accurately identified patients with BD in various clinical scenarios, and could help expedite accurate clinical diagnosis and treatment of BD.

Indexed as

Bipolar DisorderMajor Depressive DisorderAlgorithmsBiomarkersHumansMachine LearningMental HealthSurveys and QuestionnairesBiomarkers

Identifiers

PMID33436544
PMCPMC7804187
OpenAlexW3119061447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.